ArticleDrugs - real world outcomes2020

Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case-Control Study.

Nawal Farhat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.